selegiline has been researched along with Acquired Immune Deficiency Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nightingale, SL | 1 |
1 trial(s) available for selegiline and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antioxidants; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Placebos; Selegiline; Thioctic Acid; Treatment Outcome | 1998 |
2 other study(ies) available for selegiline and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
FDA approves marketing of two drugs previously available under treatment IND regulations.
Topics: Acquired Immunodeficiency Syndrome; Drugs, Investigational; Ganciclovir; Humans; Parkinson Disease; Phenethylamines; Selegiline | 1989 |
From the Food and Drug Administration.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Clinical Protocols; Didanosine; Drug Evaluation; Humans; Parkinson Disease; Phenethylamines; Selegiline; United States; United States Food and Drug Administration | 1989 |